Patrick Nachman

Emailpnachmanumnedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

1 Similar Profiles

3 Active
7 Finished

Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics
Nachman, P., Adeyi, O., Berge, J. M., Bu, L., Caramori, L., Drawz, P. E., Flanagan, S. M., Harindhanavudhi, T., Ma, S., Rosenberg, M., Safadi, S. & Wolf, S. M.
NIH Natl Inst of Diabetes/Dig/Kidney Dis
9/15/22 → 6/30/27
Project: Research project
Preparing a Clinical Outcomes Assessment set for Nephrotic Syndrome [Prepare-NS]
Nachman, P.
University of Michigan
5/1/21 → 4/30/26
Project: Research project
OMS721-IGA-001: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)
Nachman, P.
Omeros Corporation
2/1/18 → 12/31/23
Project: Research project
United States Renal Data System (USRDS)
Nachman, P.
Hennepin Healthcare Research Institute
6/8/19 → 1/2/20
Project: Research project
CL012_140: A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safetyand Efficacy of CCX140-B in Subjects with Focal Segmental Glomerulosclerosis (FSGS)
Nachman, P.
ChemoCentryx, Inc.
8/1/18 → 12/31/22
Project: Research project

84 Article
7 Letter
6 Review article
4 Chapter
More

Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
Mariani, L. H., Eddy, S., AlAkwaa, F. M., McCown, P. J., Harder, J. L., Nair, V., Eichinger, F., Martini, S., Ademola, A. D., Boima, V., Reich, H. N., El Saghir, J., Godfrey, B., Ju, W., Tanner, E. C., Vega-Warner, V., Wys, N. L., Adler, S. G., Appel, G. B., Athavale, A., & 46 othersAtkinson, M. A., Bagnasco, S. M., Barisoni, L., Brown, E., Cattran, D. C., Coppock, G. M., Dell, K. M., Derebail, V. K., Fervenza, F. C., Fornoni, A., Gadegbeku, C. A., Gibson, K. L., Greenbaum, L. A., Hingorani, S. R., Hladunewich, M. A., Hodgin, J. B., Hogan, M. C., Holzman, L. B., Jefferson, J. A., Kaskel, F. J., Kopp, J. B., Lafayette, R. A., Lemley, K. V., Lieske, J. C., Lin, J. J., Menon, R., Meyers, K. E., Nachman, P. H., Nast, C. C., O'Shaughnessy, M. M., Otto, E. A., Reidy, K. J., Sambandam, K. K., Sedor, J. R., Sethna, C. B., Singer, P., Srivastava, T., Tran, C. L., Tuttle, K. R., Vento, S. M., Wang, C. S., Ojo, A. O., Adu, D., Gipson, D. S., Trachtman, H. & Kretzler, M., Mar 2023, In: Kidney international. 103, 3, p. 565-579 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
C5a receptor inhibitor avacopan in immunoglobulin A nephropathy- A n open-label pilot study
Bruchfeld, A., Magin, H., Nachman, P., Parikh, S., Lafayette, R., Potarca, A., Miao, S. & Bekker, P., May 1 2022, In: Clinical Kidney Journal. 15, 5, p. 922-928 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy
CureGN Consortium, Nov 2022, In: Kidney International Reports. 7, 11, p. 2462-2473 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Long-Term Outcomes of Kidney Transplant Recipients with Glomerulonephritides by Induction Type and Steroid Avoidance
Ravipati, P., Jackson, S., Tumer, G., Nachman, P. H. & Riad, S. M., Mar 2022, In: Transplantology. 3, 1, p. 68-82 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Innovating and invigorating the clinical trial infrastructure for glomerular diseases
Barisoni, L., Barratt, J., Campbell, K., Eva, L., Gillespie, B. S., Gipson, D., Huber, T., Jardine, M., Kamil, E., Kretzler, M., Lee, L., Levtchenk, E., Mehr, A. P., Nachman, P. H., Oh, J., Saleem, M., Shankland, S. J., Smith, K., Smokler, I., Smoyer, W., & 8 othersTarnoff, J., Thompson, A., Trachtman, H., Udani, S., Vivarelli, M., Walker, P., West, M. & Rovin, B. H., Mar 1 2021, In: Kidney international. 99, 3, p. 519-523 5 p.
Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Patrick Nachman

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Network

Dive into details

Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & Ethics

Preparing a Clinical Outcomes Assessment set for Nephrotic Syndrome [Prepare-NS]

OMS721-IGA-001: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)

United States Renal Data System (USRDS)

CL012_140: A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safetyand Efficacy of CCX140-B in Subjects with Focal Segmental Glomerulosclerosis (FSGS)

Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis

C5a receptor inhibitor avacopan in immunoglobulin A nephropathy- A n open-label pilot study

Clinicopathologic Significance of Predominant Lambda Light Chain Deposition in IgA Nephropathy

Long-Term Outcomes of Kidney Transplant Recipients with Glomerulonephritides by Induction Type and Steroid Avoidance

Innovating and invigorating the clinical trial infrastructure for glomerular diseases

Patrick Nachman

Personal profile

Expertise related to UN Sustainable Development Goals

Fingerprint

Network

Projects

Research output